| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2971073 | The Journal of Heart and Lung Transplantation | 2010 | 8 Pages | 
Abstract
												Patients who have a VAD for >45 days should be awarded some priority for urgent HTx, which is currently prohibited in Germany. Patients listed in urgent status due to difficulties of coagulation management should be prioritized over those listed for device-related infection to make effective use of limited resources.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Takeshi MD, PhD, Thorsten MD, Roland MD, PhD, Hans B. MD, 
											